Bio report, page-39

Assumptions or wild guesses ( which you have admitted to on several occasions when cornered by other learned posters here) , which when based on conjecture do not merit a serious discussion.

However Playez your strategy has always and continues to be one of casting doubt at every opportunity on POHs tech; POHS commercial opportunity; POHs Staff; and POHs profile within the Pharma world.

As you are not I presume a Board Member or Exec at POH, it comes as no surprise that you are not in "the loop" (A) on what discussions POH is having with Pharma on its Opiod Patches ( which Paul Gavin stated clearly at the AGM are occurring); (B) what happened at Pain Week in Tampa or any other Pharma gathering; and (C) could have no knowledge as to whether Pharma reps have visited POH to examine TPM. As all of the above would be commercially sensitive POH is in no position to tell you or the market anything other than what they have revealed to date. When something is signed they will inform the market.

POH has stated it intends to license, license, license and it expects this to happen on the back of Phase 2 trial results- until then your grenade launcher should be put away....its firing blanks in any case- all noise but no substance